Cécile Dalban
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- Renal cell carcinoma treatment 22
- Brain Metastases and Treatment 4
- Ferroptosis and cancer prognosis 4
- Oncology 29
- Cancer Immunotherapy and Biomarkers 18
- CAR-T cell therapy research 4
- Co-authors
- Julien Taı̈eb (6 shared papers)Dominique Costagliola (7 shared papers)David Malka (3 shared papers)Maximilien Barret (4 shared papers)Touraj Mansourbakht (4 shared papers)Aziz Zaanan (3 shared papers)S. Antoun (2 shared papers)Franck Bonnetain (9 shared papers)
- Journals
- Journal of Clinical Oncology (17 papers)Annals of Oncology (15 papers)European Journal of Cancer (4 papers)JAMA Oncology (3 papers)AIDS (2 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Cécile Dalban
72 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Virology 156
- Infectious Diseases 314
- Geriatrics and Gerontology 49
- Otorhinolaryngology 60
- Oncology 280
Countries citing papers authored by Cécile Dalban
This map shows the geographic impact of Cécile Dalban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Dalban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Dalban more than expected).
Fields of papers citing papers by Cécile Dalban
This network shows the impact of papers produced by Cécile Dalban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Dalban. The network helps show where Cécile Dalban may publish in the future.
Co-authors
The 25 scholars most cited alongside Cécile Dalban, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 203 | |
| 2 | 2005 | 106 | |
| 3 | 2011 | 84 | |
| 4 | 2015 | 84 | |
| 5 | 2003 | 79 | |
| 6 | 2013 | 71 | |
| 7 | 2014 | 69 | |
| 8 | 2022 | 50 | |
| 9 | 2007 | 47 | |
| 10 | 2015 | 45 | |
| 11 | 2006 | 45 | |
| 12 | 2004 | 44 | |
| 13 | 2003 | 42 | |
| 14 | 2005 | 37 | |
| 15 | 2013 | 37 | |
| 16 | 2020 | 33 | |
| 17 | 2012 | 30 | |
| 18 | 2016 | 30 | |
| 19 | 2014 | 27 | |
| 20 | 2015 | 26 |
About Cécile Dalban
Cécile Dalban is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Infectious Diseases, having authored 75 papers that have together received 1.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (22 papers), Cancer Immunotherapy and Biomarkers (18 papers), Ovarian cancer diagnosis and treatment (5 papers), HIV/AIDS drug development and treatment (5 papers), Nutrition and Health in Aging (4 papers), Brain Metastases and Treatment (4 papers), Ferroptosis and cancer prognosis (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Virology (156 citations), Infectious Diseases (314 citations), Geriatrics and Gerontology (49 citations), Otorhinolaryngology (60 citations) and Oncology (280 citations). Cécile Dalban has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Julien Taı̈eb, Dominique Costagliola, David Malka, Maximilien Barret, Touraj Mansourbakht, Aziz Zaanan, S. Antoun, Franck Bonnetain, Pierre Quartier and Isabelle Funck-Brentano. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, JAMA Oncology and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.